SERUM OSTEOPROTEGERIN FOR EARLY IDENTIFICATION OF CAD IN TYPE 2 DM PATIENTS. IJeR. 2025;2(3):20-50. Accessed May 18, 2026. https://ijeres.org/index.php/ijer/article/view/10